209 related articles for article (PubMed ID: 30193786)
21. [Incidence and Risk Factors of Hypokalemia in Tazobactam/Piperacillin-administered Patients].
Kuramoto H; Masago S; Kashiwagi Y; Maeda M
Yakugaku Zasshi; 2019; 139(12):1591-1600. PubMed ID: 31787649
[TBL] [Abstract][Full Text] [Related]
22. [Comprehensive evaluation of pharmacokinetic and clinical studies on tazobactam/piperacillin in pediatric field].
Fujii R; Okuno A; Fujita K; Yoshikawa M; Inyaku F; Takimoto M; Saijo M; Wagatsuma S; Fukushima N; Ishikawa A
Jpn J Antibiot; 1995 Mar; 48(3):311-45. PubMed ID: 7752448
[TBL] [Abstract][Full Text] [Related]
23. [Pharmacokinetic and clinical evaluation of tazobactam/piperacillin in the pediatric field].
Toyonaga Y; Ishihara T; Tezuka T; Nakamura H
Jpn J Antibiot; 1998 May; 51(5):325-45. PubMed ID: 9693966
[TBL] [Abstract][Full Text] [Related]
24. [Mutagenicity tests of tazobactam/piperacillin, tazobactam and piperacillin].
Ohuchida A; Taniguti A; Kouchi Y; Maeda Y; Kashihara A; Omae S
J Toxicol Sci; 1994 Oct; 19 Suppl 2():263-80. PubMed ID: 7830291
[TBL] [Abstract][Full Text] [Related]
25. Piperacillin/tazobactam-induced sudden severe thrombocytopenia in a patient with a pressure ulcer: a case report.
Roh S; Hashimoto K; Kiriishi R; Matsubara K; Isozaki Y; Tanaka H; Kuwata T
J Wound Care; 2024 Jun; 33(Sup6):S25-S30. PubMed ID: 38843043
[TBL] [Abstract][Full Text] [Related]
26. Frequency of Acute Kidney Injury Caused by Tazobactam/Piperacillin in Patients with Pneumonia and Chronic Kidney Disease: A Retrospective Observational Study.
Morimoto T; Nagashima H; Morimoto Y; Tokuyama S
Yakugaku Zasshi; 2017; 137(9):1129-1136. PubMed ID: 28867699
[TBL] [Abstract][Full Text] [Related]
27. Analysis of isolated bacteria and short-term antimicrobial prophylaxis with tazobactam-piperacillin (1:4 ratio) for prevention of postoperative infections after radical cystectomy.
Tanaka K; Arakawa S; Miura T; Shigemura K; Nakano Y; Takahashi S; Tsukamoto T; Matsumoto T; Fujisawa M
J Infect Chemother; 2012 Apr; 18(2):175-9. PubMed ID: 22002577
[TBL] [Abstract][Full Text] [Related]
28. Nephrotoxicity induced by piperacillin–tazobactam in late elderly Japanese patients with nursing and healthcare associated pneumonia.
Karino F; Nishimura N; Ishihara N; Moriyama H; Miura K; Hamaguchi S; Sutani A; Kuraki T; Ikawa K; Morikawa N
Biol Pharm Bull; 2014; 37(12):1971-6. PubMed ID: 25590089
[TBL] [Abstract][Full Text] [Related]
29. [Reproductive and developmental toxicity studies of tazobactam/piperacillin or tazobactam (2)--Teratological study in rats with intravenously administration].
Sato T; Lochry EA; Hoberman AM; Christian MS
J Toxicol Sci; 1994 Oct; 19 Suppl 2():215-32. PubMed ID: 7830288
[TBL] [Abstract][Full Text] [Related]
30. Ceftriaxone versus tazobactam/piperacillin and carbapenems in the treatment of aspiration pneumonia: A propensity score matching analysis.
Asai N; Suematsu H; Ohashi W; Shibata Y; Sakanashi D; Kato H; Shiota A; Watanabe H; Hagihara M; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2021 Oct; 27(10):1465-1470. PubMed ID: 34158237
[TBL] [Abstract][Full Text] [Related]
31. [Antigenicity tests of tazobactam/piperacillin, tazobactam and piperacillin].
Takemoto M; Matsuo K; Oguro M; Kouchi Y
J Toxicol Sci; 1994 Oct; 19 Suppl 2():249-62. PubMed ID: 7830290
[TBL] [Abstract][Full Text] [Related]
32. [Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field].
Shinagawa N; Yura J; Mashita K; Matsuno S; Rikiyama T; Hirayama T; Tanaka T; Otsuka K; Iwai S; Nakagawa Y
Jpn J Antibiot; 1995 Mar; 48(3):346-67. PubMed ID: 7752449
[TBL] [Abstract][Full Text] [Related]
33. [Single-dose toxicity studies of tazobactam/piperacillin and tazobactam].
Hayashi T; Yada H; Anai M; Umano T; Kawazu K; Anai S; Kaziwara T; Yamasaki K
J Toxicol Sci; 1994 Oct; 19 Suppl 2():145-53. PubMed ID: 7830284
[TBL] [Abstract][Full Text] [Related]
34. [A six-month intraperitoneal repeated dose toxicity study of tazobactam/piperacillin and tazobactam in rats].
Hayashi T; Yada H; Auletta CS; Daly IW; Knezevich AL; Cockrell BY
J Toxicol Sci; 1994 Oct; 19 Suppl 2():155-76. PubMed ID: 7830285
[TBL] [Abstract][Full Text] [Related]
35. A prospective randomized trial comparing piperacillin/tazobactam with meropenem as empirical antibiotic treatment of febrile neutropenic children and adolescents with hematologic and malignant disorders.
Sano H; Kobayashi R; Suzuki D; Hori D; Kishimoto K; Kobayashi K
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27873451
[TBL] [Abstract][Full Text] [Related]
36. Risk Factors for Teicoplanin-Associated Acute Kidney Injury in Patients with Hematological Malignancies: Focusing on Concomitant Use of Tazobactam/Piperacillin.
Morinaga Y; Tanaka R; Tatsuta R; Takano K; Hashimoto T; Ogata M; Hiramatsu K; Itoh H
Biol Pharm Bull; 2024; 47(5):988-996. PubMed ID: 38763761
[TBL] [Abstract][Full Text] [Related]
37. Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients.
Kobayashi R; Sato T; Nakajima M; Kaneda M; Iguchi A
J Pediatr Hematol Oncol; 2009 Apr; 31(4):270-3. PubMed ID: 19346879
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of antibiotic prophylaxis against ventilator-associated pneumonia.
Mirtalaei N; Farazi A; Ebrahimi Monfared M; Jokar A
J Hosp Infect; 2019 Mar; 101(3):272-275. PubMed ID: 30179656
[TBL] [Abstract][Full Text] [Related]
39. [Reproductive and developmental toxicity studies of tazobactam/piperacillin or tazobactam (3)--Perinatal and postnatal study in rats with intraperitoneal administration].
Sato T; Hoberman AM; Christian MS
J Toxicol Sci; 1994 Oct; 19 Suppl 2():233-47. PubMed ID: 7830289
[TBL] [Abstract][Full Text] [Related]
40. [Clinical studies of tazobactam/piperacillin (TAZ/PIPC) in pediatric patients].
Waga S; Yokoyama M; Tsushima T; Chiba C; Saito T; Okamoto T; Asuka T; Kitazawa J; Tateyama N; Sato Y; Takahashi Y
Jpn J Antibiot; 1998 May; 51(5):305-18. PubMed ID: 9693964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
